This activation mechanism would contribute to the promotion of cardiac hypertrophy caused by chronic α1 adrenergic stimulation in vivo, since overexpression of the non-phosphorylated mutant of the β2a subunit failed to display enhancement of cardiac hypertrophy (Tonegawa et al., 2017). Here, KRTAP1-1 is linked to cardiac hypertrophy.